TTY Biopharm Company Limited (TPEX:4105)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
75.30
-0.40 (-0.53%)
Jul 30, 2026, 11:23 AM CST

Revenue by Segment

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Export and OEM Business Unit
1.25B1.02B796.70M653.68M-
Healthcare Unit
263.43M262.41M195.63M581.66M221.48M
Re-investment Business Unit
1.43B1.24B814.45M747.28M-
Intensive Care Business Unit
1.50B1.32B1.20B899.62M1.14B
Adjustments and Eliminations
-512.98M-444.41M--268.62M-274.72M
Oncology Business Unit
2.50B2.46B2.43B2.34B2.77B
Other Business Unit
21.92M35.23M65.44M106.64M270.72M
Cardiovascular and Gastrointestinal Drugs Business Group
----413.48M
Total
6.45B5.89B5.51B5.06B4.54B

Revenue by Geography

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Taiwan
5.49B5.12B4.84B4.60B4.25B
America
557.54M381.29M265.71M59.43M-
Other Countries
405.11M391.78M398.66M402.12M289.25M
Total
6.45B5.89B5.51B5.06B4.54B